Shalabh Gupta
2021 - Unicycive Therapeutics
In 2021, Shalabh Gupta earned a total compensation of $1.1M as Chief Executive Officer at Unicycive Therapeutics, a 75% increase compared to previous year.
Compensation breakdown
| Bonus | $124,187 |
|---|---|
| Option Awards | $330,729 |
| Salary | $669,775 |
| Total | $1,124,691 |
Gupta received $669.8K in salary, accounting for 60% of the total pay in 2021.
Gupta also received $124.2K in bonus and $330.7K in option awards.
Rankings
In 2021, Shalabh Gupta's compensation ranked 8,381st out of 12,415 executives tracked by ExecPay. In other words, Gupta earned more than 32.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,381 out of 12,415 | 33rd |
Division Manufacturing | 3,712 out of 5,508 | 33rd |
Major group Chemicals And Allied Products | 1,650 out of 2,378 | 31st |
Industry group Drugs | 1,468 out of 2,099 | 30th |
Industry Pharmaceutical Preparations | 1,093 out of 1,549 | 29th |
Source: SEC filing on April 19, 2022.
Gupta's colleagues
We found two more compensation records of executives who worked with Shalabh Gupta at Unicycive Therapeutics in 2021.